Identifying Risk Factors for MRI-Invisible Prostate Cancer in Patients Undergoing Transperineal Saturation Biopsy

Identifying Risk Factors for MRI-Invisible Prostate Cancer in Patients Undergoing Transperineal Saturation Biopsy

Alberto Artiles Medina, Rafael Rodríguez-Patrón Rodríguez, Mercedes Ruiz Hernández, Marina Mata Alcaraz, Silvia García Barreras, Guillermo Fernández Conejo, Agustín Fraile Poblador, Enrique Sanz Mayayo, Francisco Javier Burgos Revilla Department of Urology, Hospital Universitario Ramón y Cajal, Univ...

Full description

Bibliographic Details
Main Authors:	Artiles Medina A, Rodríguez-Patrón Rodríguez R, Ruiz Hernández M, Mata Alcaraz M, García Barreras S, Fernández Conejo G, Fraile Poblador A, Sanz Mayayo E, Burgos Revilla FJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-09-01
Series:	Research and Reports in Urology
Subjects:	clinically significant prostate cancer multi-parametric magnetic resonance imaging negative mri prostate cancer saturation biopsy
Online Access:	https://www.dovepress.com/identifying-risk-factors-for-mri-invisible-prostate-cancer-in-patients-peer-reviewed-fulltext-article-RRU

Similar Items

Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer
by: Sergey Nikolaevich Novikov, et al.
Published: (2016-04-01)

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
by: Hai Zhu, et al.
Published: (2022-06-01)

Clinical Value of Core Lenght in Saturation Prostate Biopsy
by: Cem Yücel, et al.
Published: (2018-06-01)

Comparative study of the values of transperineal and transrectal prostate puncture in diagnosis of prostate cancer in patients with gray/sub-gray zone of PSA
by: Wang Hailuo, Pang Kun, Wang Jingkai, Xu Peng, Xu Hao, Pan Deng, Ma Yuyang, Zhang Ruoran, Han Conghui
Published: (2024-02-01)

Transperineal US-MRI Fusion-Guided Biopsy for the Detection of Clinical Significant Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Cognitive and Software-Assisted Technique
by: Giacomo Maria Pirola, et al.
Published: (2023-06-01)

A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate
by: Po-Fan Hsieh, et al.
Published: (2022-04-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
by: Alvydas Vėželis, et al.
Published: (2021-01-01)

Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer
by: Xiaoying Wang, et al.
Published: (2022-02-01)

Factors predicting positive saturation biopsy in prostate cancer patients with prior negative multiparametric magnetic resonance imaging
by: A. Artiles Medina, et al.
Published: (2020-11-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Conﬁrmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassiﬁcation rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy
by: Pietro Pepe, et al.
Published: (2022-09-01)

Does prolonged anti-inflammatory therapy reduce number of unnecessary repeat saturation prostate biopsy?
by: Giuseppe Candiano, et al.
Published: (2013-06-01)

Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate
by: Lei Wang, et al.
Published: (2019-11-01)

Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study
by: Giacomo M. Pirola, et al.
Published: (2022-03-01)

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
by: Yasushi Nakai, et al.
Published: (2017-04-01)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
by: Furat Abd Ali, et al.
Published: (2023-08-01)

A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer
by: Carmelo Agostino Di Franco, et al.
Published: (2017-03-01)

COMPARISON BETWEEN TRANSRECTAL ULTRASONOGRAPHY GUIDED TRANSRECTAL PROSTATE BIOPSY AND TRANSRECTAL ULTRASONOGRAPHY GUIDED TRANSPERINEAL PROSTATE BIOPSY
by: Randa Halfian, et al.
Published: (2019-07-01)

Anxiety and Depression are Two Important Causes of Erectile Dysfunction after Saturation Biopsy: A Pilot Study
by: Cem Akbal, et al.
Published: (2014-11-01)

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
by: Heather Johnson, et al.
Published: (2020-12-01)

Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical Features
by: Francesco Prata, et al.
Published: (2023-02-01)

Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
by: Pietro Pepe, et al.
Published: (2013-09-01)

68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone
by: Jinhui Yang, et al.
Published: (2023-09-01)

Impact of transperineal ultrasound on perineal skin dose in prostate radiation therapy
by: Kalani De Silva, et al.
Published: (2022-09-01)

Impact on prostate cancer clinical presentation after non-screening policies at a tertiary-care medical center- a retrospective study
by: Tarek Ajami, et al.
Published: (2021-02-01)

Evaluation of transperineal ultrasound imaging as a potential solution for target tracking during hypofractionated radiotherapy for prostate cancer
by: Bin Han, et al.
Published: (2018-08-01)

Utility of Multiparametric Magnetic Resonance Imaging as a Predictor of Clinically Significant Prostate Cancer in a Sub-Saharan African Population
by: Mariah Kerubo Obino, et al.
Published: (2022-04-01)

CT-PLANNED transperineal prostate BIOPSY IN patients without a rectum
by: Gregory S. Merrick, et al.
Published: (2020-11-01)

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center
by: Philipp Krausewitz, et al.
Published: (2024-03-01)

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
by: Juan Morote, et al.
Published: (2022-05-01)

Shifting to transperineal prostate biopsy: A narrative review
by: Younsoo Chung, et al.
Published: (2024-03-01)

Importance of Malignant Core Length in the Detection of Clinically Significant Prostate Cancer in Transrectal Prostate Biopsies
by: Gökçe Dündar, et al.
Published: (2023-06-01)

Continued administration of antithrombotic agents during transperineal prostate biopsy
by: Toko Asano, et al.
Published: (2015-02-01)

Transperineal ultrasound-guided prostate biopsy: what the radiologist needs to know
by: Jack Power, et al.
Published: (2022-04-01)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan Profiling
by: Sarah Gilgunn, et al.
Published: (2020-12-01)

Transperineal Parallel Biopsy of the Prostate: A New Approach of Tissue Sampling for Precision Medicine
by: Qu M, et al.
Published: (2021-05-01)

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
by: Yin Lei, et al.
Published: (2022-09-01)

A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies
by: Juan Morote, et al.
Published: (2023-09-01)

Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy
by: Wenming Ren, et al.
Published: (2022-12-01)